Table 2.
Within-patients ANOVA differences in brain activation between the MPH and the placebo conditions during time discrimination versus order judgement. (BA, Brodman area; N voxels, number of voxels; Tal. co-ordinates, Talairach coordinates. p-value for ANCOVAs at p<0.05 for voxel activation and p<0.006 for cluster activation.)
brain region | BA | Tal. coordinates (x, y, z) | N voxels | cluster p-value |
---|---|---|---|---|
(a) methylphenidate>placebo | ||||
L orbitofrontal/inferior frontal gyri/insula | 47/45 | −33, −11, −2 | 419 | 0.002 |
R medial prefrontal gyrusa | 46 | 40, 44, 9 | 38 | 0.02 |
L anterior cingulated gyrusa | 32 | −6, 37, 26 | 35 | 0.03 |
R lateral cerebelluma | 14, −52, 46 | 30 | 0.05 | |
(b) placebo>methylphenidate | ||||
R inferior/medial frontal gyri/insula | 9/8/44 | 25, 15, 28 | 25 | 0.002 |
R superior frontal gyrus | 8 | 18, 30, 49 | 14 | 0.003 |
R medial temporal lobe | 22 | 29, −33, 7 | 23 | 0.002 |
R hippocampus, hippocampal gyrus | 35 | 22, −15, −7 | 41 | 0.002 |
R putamen and globus pallidus | 11 | 29, −11, 7 | 11 | 0.002 |
Large three-dimensional clusters were broken into smaller two-dimensional clusters.